The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its DebutInvestors Business Daily • 09/18/25
COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child DeathsZacks Investment Research • 09/15/25
COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report saysMarket Watch • 09/12/25
BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains?Zacks Investment Research • 09/12/25
BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trialReuters • 09/08/25
First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor ActivityGlobeNewsWire • 09/08/25
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 FormulaBusiness Wire • 09/08/25
BioNTech Surges 10% On Promising Test Results For Its Cancer Smart BombInvestors Business Daily • 09/05/25
RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.Investors Business Daily • 08/27/25
Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19Business Wire • 08/27/25
BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives GrowthBenzinga • 08/04/25
BioNTech Announces Second Quarter 2025 Financial Results and Corporate UpdateGlobeNewsWire • 08/04/25